A single-arm, retrospective analysis of the incidence of febrile neutropenia using same-day versus next-day pegfilgrastim in patients with gastrointestinal cancers treated with FOLFOX or FOLFIRI

被引：0
|
作者：
John Eckstrom
Trace Bartels
Ivo Abraham
Hitendra Patel
Emad Elquza
Aaron J Scott
Steven Malangone
Jerrelee Hollings
Ali McBride
机构：
[1] University of Arizona Cancer Center/Banner-University Medical Center Tucson,
[2] The University of Arizona College of Pharmacy,undefined
[3] University of California San Diego Health/Moores Cancer Center,undefined
来源：
Supportive Care in Cancer | 2019年 / 27卷
关键词：
Gastrointestinal cancers; FOLFOX; FOLFIRI; Same-day pegfilgrastim; Febrile neutropenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：873 / 878
页数：5
相关论文
共 7 条
  • [1] A single-arm, retrospective analysis of the incidence of febrile neutropenia using same-day versus next-day pegfilgrastim in patients with gastrointestinal cancers treated with FOLFOX or FOLFIRI
    Eckstrom, John
    Bartels, Trace
    Abraham, Ivo
    Patel, Hitendra
    Elquza, Emad
    Scott, Aaron J.
    Malangone, Steven
    Hollings, Jerrelee
    McBride, Ali
    SUPPORTIVE CARE IN CANCER, 2019, 27 (03) : 873 - 878
  • [2] Real-world febrile neutropenia rates with same-day versus next-day pegfilgrastim after myelosuppressive chemotherapy
    Kitchen, Kyle
    Mosier, Michael C.
    FUTURE ONCOLOGY, 2022, 18 (23) : 2551 - 2560
  • [3] Risk of chemotherapy-induced febrile neutropenia with same-day versus next-day pegfilgrastim prophylaxis among patients aged ≥65 years: a retrospective evaluation using Medicare claims
    Weycker, Derek
    Hanau, Ahuva
    Lonshteyn, Alexander
    Bowers, Charles
    Bensink, Mark
    Garawin, Tamer
    Chandler, David
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (09) : 1705 - 1711
  • [4] Same-day versus next-day pegfilgrastim or pegfilgrastim-cbqv in patients with lymphoma receiving CHOP-like chemotherapy
    McBride, Ali
    Alrawashdh, Neda
    Bartels, Trace
    Moore, Logan
    Persky, Daniel
    Abraham, Ivo
    FUTURE ONCOLOGY, 2021, 17 (26) : 3485 - 3497
  • [5] Efficacy of same-day versus next-day administration of pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients receiving dose-dense doxorubicin and cyclophosphamide: A retrospective multi-site analysis
    Hobbs, Jacob
    Lowe, Jan
    Ferdinand, Abigale
    Shook, Anna
    Beck, Bradley
    Blais, Danielle
    Borchardt, Cole
    Xu, Bing
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (08) : 1853 - 1861
  • [6] Efficacy and safety of same-day versus next-day administration of PEG-rhG-CSF for the prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia in patients with breast cancer: a retrospective cohort study
    Zhang, Yu-Fei
    Zhang, Rou-Mei
    Gu, Wen-Xin
    Jin, Yi-Ting
    Ma, Chun-Lai
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, : 2147 - 2154
  • [7] Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial
    Park, Kwonoh
    Jeon, Young-Kyung
    Kim, Jung Hoon
    Choi, Younak
    Kim, Jae-Joon
    Oh, Sang-Bo
    Oh, So Yeon
    Hong, Yun Jeong
    Huh, Seok Jae
    Kim, Ilhwan
    Shin, Seong Hoon
    MEDICINE, 2023, 102 (20) : E33638
1